Insoluble wild−type and protease−resistant mutant prion protein in brains of patients with inherited prion disease

1. Prusiner, S.B. Inherited prion diseases. Proc. Natl. Acad. Sci. USA 91, 4611−4614 (1994).
2. Masters, C.L., Gajdusek, D.C. & Gibbs, C.J., Creutzfeldt-Jakob disease virus isolations from the Gerstmann-Straussler syndrome. Brain 1O4, 559−588 (1981).
3. Hsiao, K. et al. Linkage of a prion protein missense variant to Gerstmann-Straussler syndrome. Nature 338, 342−345 (1989).
4. Goldfarb, L.G. et al. Fatal familial insomnia and familial Creutzfeldt-Jakob disease: Disease phenotype determined by a DNA polymorphism. Science 258, 806−808 (1992).
5. Kahana, E., Milton, A., Braham, J. & Sofer, D. Creutzfeldt−Jakob disease: Focus among Libyan Jews in Israel. Science 183, 90−91 (1974).
6. Goldfarb, L., Korczyn, A., Brown, P., Chapman, J. & Gajdusek, D.C. Mutation in codon 200 of scrapie amyloid precursor gene linked to Creutzfeldt-Jakob disease in Sephardicjews of Libyan and non-Libyan origin. Lancet 336, 637−638 (1990).
7. Hsiao, K. et al. Mutationof the prion proteininLibyan Jews with Creutzfeldt-Jakob disease. N. Engl. J. Med. 324, 1091−1097 (1991).
8. Gabizon, R. et al. Mutation and polymorphism of the prion protein gene in Libyan Jews with Creutzfeldt-Jakob disease. Am. J. Hum. Genet. 33, 828−835 (1993).
9. Goldfarb, L.G., Mitrova, E., Brown, P., Toh, B.H. & Gajdusek, D.C. Mutation in codon 200 of scrapie amyloid protein gene in two clusters of Creutzfeldt-Jakob disease in Slovakia. Lancet 336, 514−515 (1990).
10. Brown, P. et al. Familial Creutzfeldt-Jakob disease in Chile is associated with the codon 200 mutation of the PRNP amyloid precursor gene on chromosome 20. J. Neural. Sci. 112, 65−67 (1992).
11. Collinge, J. et al. Inherited prion disease (PrP lysine 200) in Britain: Two case reports. Br. Med. J. 306, 391−392 (1993).
12. Bertoni, J.M., Brown, P., Goldfarb, L., Gajdusek, D. & Omaha, N.E., Creutzfeldt−Jakob disease with the PRNP codon 200^lys mutation and supranuclear palsy but without myoclonus or periodic EEG complexes (Abstr). Neurology 42 (No.4 Suppl. 3), 350 (1992).
13. Chapman, J., Ben-Israel, J., Goldhammer, Y. & Korczyn, A.D. The risk of developing Creutzfeldt−Jakob disease in subjects with the PRNP gene codon 200 point mutation. Neurology 44, 1683−1686 (1994).
14. Spudich, S. et al. Complete penetrance of Creutzfeldt-Jakob disease in Libyan Jews carrying the E200K mutation in the prion protein gene. Mol. Med. 1, 607−613 (1995).
15. Prusiner, S.B. Molecular biology of prion diseases. Science 252, 1515−1522 (1991).
16. Pan, K.-M. et al. Conversion of a-helices into b-sheets features in the formation of the scrapie prion proteins. Proc. Natl. Acad. Sci. USA 90, 10962−10966 (1993).
17. Huang, Z. et al. Proposed three-dimensional structure for the cellular prion protein. Proc. Natl. Acad. Sci. USA 91, 7139−7143 (1994).
18. Safar, J., Roller, P.P., Gajdusek, D.C. & Gibbs, C.J., Jr. Conformational transitions, dissociation, and unfolding of scrapie amyloid (prion) protein. J. Biol. Chem. 268, 20276−20284 (1993).
19. Kitamoto, T., Yamaguchi, K., Doh-ura, K. & Tateishi, J. A prion protein missense variant is integrated in kuru plaque cores in patients with Gerstmann-Straussler syndrome. Neurology 41, 306−310 (1991).
20. Kitamoto, T., Iizuka, R., & Tateishi, J. An amber mutation of prion protein in Gerstmann-Straussler syndrome with mutant PrP plaques. Biochem. Biophys. Res. Commun. 192, 525−531 (1993).
21. Tagliavini, F. et al. Amyloid fibrils in Gerstmann-Straussler-Scheinker disease (Indiana and Swedish kindreds) express only PrP peptides encoded by the mutant allele. Cell 79, 695−703 (1994).
22. Meyer, R.K. et al. Separation and properties of cellular and scrapie prion proteins. Proc. Natl. Acad. Sci. USA 83, 2310−2314 (1986).
23. Kascsak, R.J. et al. Mouse polyclonal and monoclonal antibody to scrapie-asso-ciated fibril proteins. J. Virol. 61, 3688−3693 (1987).
24. Rogers, M., Taraboulos, A., Scott, M., Groth, D. & Prusiner, S.B. Intracellular accumulation of the cellular prion protein after mutagenesis of its Asn-linked gly-cosylation sites. Glycobiology 1, 101−109 (1990).
25. Goldfarb, L.G. et al. New mutation in scrapie amyloid precursor gene (at codon 178) in Finnish Creutzfeldt−Jakob kindred. Lancet 337, 425 (1991).
26. Hsiao, K. et al. Mutant prion proteins in Gerstmann-Straussler-Scheinker disease with neurofibrillary tangles. Nature Genet. 1, 68−71 (1992).
27. Monari, L. et al. Fatal familial insomnia and familial Creutzfeldt−Jakob disease: Different prion proteins determined by a DNA polymorphism. Proc. Natl. Acad. Sci. USA 91, 2839−2842 (1994).
28. Gasset, M., Baldwin, M.A., Fletterick, R.J. & Prusiner, S.B. Perturbation of the secondary structure of the scrapie prion protein under conditions associated with changes in infectivity. Proc. Natl. Acad. Sci. USA 90, 1−5 (1993).
29. Gabizon, R., McKinley, M.P., Groth, D.F., Kenaga, L. & Prusiner, S.B. Properties of scrapie prion liposomes. J. Biol. Chem. 263, 4950−4955 (1988).
30. Goldfarb, L.G. et al. Synthetic peptides corresponding to different mutated regions of the amyloid gene in familial Creutzfeldt−Jakob disease show enhanced in vitro formation of morphologically different amyloid fibrils. Proc. Natl. Acad. Sci. USA 90, 4451−4454 (1993).
31. Gasset, M. et al. Predicted -helical regions of the prion protein when synthesized as peptides form amyloid. Proc. Natl. Acad. Sci. USA 89, 10940−10944 (1992).
32. Come, J.H., Fraser, P.E. & Lansbury, P.T., A kinetic model for amyloid formation in the prion diseases: Importance of seeding. Proc. Natl. Acad. Sci. USA 90, 5959−5963 (1993).
33. Forloni, G. et al. Neurotoxicity of a prion protein fragment. Nature 362, 543−546 (1993).
34. Nguyen, J., Baldwin, M.A., Cohen, F.E. & Prusiner, S.B. Prion protein peptides induce -helix to -sheet conformation altransitions. Biochemistry 34, 4186−4192 (1995).
35. Meiner, Z., Halimi, M., Polakiewicz, R.D., Prusiner, S.B. & Gabizon, R. Presence of the prion protein in peripheral tissues of Libyan Jews with Creutzfeldt−Jakob disease. Neurology 42, 1355−1360 (1992).
36. Taraboulos, A. et al. Acquisition of protease resistance by prion proteins in scrapie-infected cells does not require asparagine-linked glycosylation. Proc. Natl. Acad. Sci. USA 87, 8262−8266 (1990).
37. Prusiner, S.B. et al. Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication. Cell 63, 673−686 (1990).
38. Kimberlin, R.H. & Walker, C.A. The antiviral compound HPA-23 can prevent scrapie when administered at the time of infection. Arch. Virol. 78, 9−18 (1983).
39. Ehlers, B. & Diringer, H. Dextran sulphate 500 delays and prevents mouse scrapie by impairment of agent replication in spleen. J. Gen. Virol. 65, 1325−1330 (1984).
40. Diringer, H. & Ehlers, B. Chemoprophylaxis of scrapie in mice. J. Gen. Virol. 72, 457−460 (1991).
41. Caughey, B. & Race, R.E. Potent inhibition of scrapie-associated PrP accumulation by Congo red. J. Neumchem. 59, 768−771 (1992).
42. Caughey, B. & Raymond, G.J. Sulfated polyanion inhibition of scrapie-associated PrP accumulation in cultured cells. J. Virol. 67, 643−650 (1993).
43. Ladogana, A. et al. Sulphate polyanions prolong the incubation period of scrapie-infected hamsters. J. Gen. Virol. 73, 661−665 (1992).
44. Ingrosso, L., Ladogana, A. & Pocchiari, M. Congo red prolongs the incubation period in scrapie-infected hamsters. J. Virol. 69, 506−508 (1995).
45. Gabizon, R., Meiner, Z., Halimi, M. & Ben-Sasson, S.A. Heparin-like molecules bind differentially to prion-proteins and change their intracellular metabolic fate. J. Cell. Physiol. 157, (1993).
46. Telling, G.C. et al. Transmission of Creutzfeldt−Jakob disease from humans to transgenic mice expressing chimeric human-mouse prion protein. Proc. Natl. Acad. Sci. USA 91, 9936−9940 (1994).
47. Telling, G.C. et al. Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein. Cell 83, 79−90 (1995).

	Top

	Top